Search
Search Constraints
You searched for: Author/Creator Mirshahidi, Hamid- Mirshahidi, Hamid [remove] 3
- 616.07 1
- AE adverse event -- ALK anaplastic lymphoma kinase -- ALK+ anaplastic lymphoma kinase positive -- AUC area under the plasma drug concentration–time curve -- AUCinf AUC from time 0 extrapolated to infinite time -- CI confidence interval -- Cmax maximum plasma drug concentration -- CNS central nervous system -- EML4-ALK echinoderm microtubule–associated protein-like 4-ALK -- FDA US Food and Drug Administration -- GI gastrointestinal -- NSCLC non-small cell lung cancer -- ORR overall response rate -- PFS progression-free survival -- PK pharmacokinetic -- QD once daily -- TKI tyrosine kinase inhibitor -- Tmax time to reach maximum plasma drug concentration 1
- Biochemical markers -- Periodicals 1
- Ceritinib -- Anaplastic lymphoma kinase -- Non-small cell lung cancer -- Food-effect trial -- Pharmacokinetics -- Gastrointestinal adverse events 1
- Pathology -- Periodicals 1
- SYT-SSX -- CDCA2 -- KIF14 -- IGFBP7 -- Secernin-1 -- E2H2 -- MMPs -- NY-ESO-1 -- CXCR4 1